BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 14661127)

  • 1. [Improved detection and characterisation of liver tumors with echo-enhanced ultrasound].
    Schuessler G; Ignee A; Hirche T; Dietrich CF
    Z Gastroenterol; 2003 Dec; 41(12):1167-76. PubMed ID: 14661127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of focal liver lesions with contrast enhanced ultrasonography.
    Dietrich CF
    Eur J Radiol; 2004 Jun; 51 Suppl():S9-17. PubMed ID: 15234021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
    Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver tumor as incidental ultrasound finding].
    Görtz RS; Strobel D
    MMW Fortschr Med; 2010 Jan; 152(3):41-3. PubMed ID: 20333967
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver tumor characterization--comments and illustrations regarding guidelines.
    Dietrich CF
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S22-30. PubMed ID: 22723025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
    Park YS; Lee CH; Kim JW; Shin S; Park CM
    World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of hepatic tumors with contrast-enhanced ultrasound and digital grey-scale analysis].
    Lemke AJ; Chopra SS; Hengst SA; Brinkmann MJ; Steinmüller T; Felix R
    Rofo; 2004 Nov; 176(11):1607-16. PubMed ID: 15497079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients].
    Bartolotta TV; Sandonato L; Taibbi A; Latteri S; Soresi M; Lombardo G; Genova C; Latteri MA
    Chir Ital; 2009; 61(3):295-307. PubMed ID: 19694231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of focal hepatic lesions with ultrasound contrast agents.
    Sutherland T; Temple F; Lee WK; Hennessy O
    J Clin Ultrasound; 2011 Sep; 39(7):399-407. PubMed ID: 21674510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions.
    Morin SH; Lim AK; Cobbold JF; Taylor-Robinson SD
    World J Gastroenterol; 2007 Dec; 13(45):5963-70. PubMed ID: 18023084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound.
    Dietrich CF; Schuessler G; Trojan J; Fellbaum C; Ignee A
    Br J Radiol; 2005 Aug; 78(932):704-7. PubMed ID: 16046421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.
    Sheybani A; Gaba RC; Lokken RP; Berggruen SM; Mar WA
    Curr Gastroenterol Rep; 2017 Oct; 19(11):58. PubMed ID: 29044439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal liver lesions: contrast-enhanced ultrasound.
    Bartolotta TV; Taibbi A; Midiri M; Lagalla R
    Abdom Imaging; 2009; 34(2):193-209. PubMed ID: 18317833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver tumor characterization--review of the literature.
    Dietrich CF; Maddalena ME; Cui XW; Schreiber-Dietrich D; Ignee A
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S3-10. PubMed ID: 22723026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-Enhanced Ultrasound of Focal Liver Lesions.
    D'Onofrio M; Crosara S; De Robertis R; Canestrini S; Mucelli RP
    AJR Am J Roentgenol; 2015 Jul; 205(1):W56-66. PubMed ID: 26102419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
    Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E
    BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.